Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure

被引:31
|
作者
Aaser, E [1 ]
Gullestad, L [1 ]
Tollofsrud, S [1 ]
Lundberg, J [1 ]
Hall, C [1 ]
Djoseland, O [1 ]
Kjekshus, J [1 ]
Forfang, K [1 ]
机构
[1] KAROLINSKA INST,INST PHYSIOL & PHARMACOL,STOCKHOLM,SWEDEN
关键词
antidiuretic hormone; big-endothelin; epinephrine; neuropeptide Y; norepinephrine; pro-ANF;
D O I
10.3109/00365519709099409
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Previous studies have demonstrated that continuous infusion of furosemide results in increased diuresis and natriuresis compared with bolus administration of the drug in patients with severe heart failure. We reasoned that continuous infusion of furosemide caused less activation of neurohumoral mechanisms, since other studies have shown that bolus administration of furosemide may activate this system. We therefore tested the hypothesis that continuous administration of furosemide would increase water and sodium excretion due to less activation of neurohormones. Eight patients with severe heart failure were studied during continuous infusion over 24 h and bolus injections of furosemide twice daily in a randomized cross-over study. Bolus administration of furosemide increased diuresis and natriuresis significantly in the first 4 h after administration compared with continuous administration, but this was later reversed, resulting in similar 24 h total output. The neurohormones measured at baseline were all markedly elevated. Neither regimens of furosemide caused any further significant changes in neurohumoral response except that pro-ANF decreased more during the first 8 h after bolus administration compared to continuous infusion. This study:has demonstrated that bolus administration of furosemide in conventional doses is equally effective as continuous intravenous infusion in patients with severe heart failure. This may be due to maximal neurohormonal activation in severe heart failure (NYHA III-IV) which could not be further activated by bolus administration.
引用
收藏
页码:361 / 367
页数:7
相关论文
共 50 条
  • [41] AORTIC INPUT IMPEDANCE AND NEUROHORMONAL ACTIVATION IN PATIENTS WITH MILD TO MODERATE CHRONIC CONGESTIVE-HEART-FAILURE
    KROMER, EP
    ELSNER, D
    HOLMER, SR
    MUNTZE, A
    RIEGGER, GAJ
    [J]. CARDIOVASCULAR RESEARCH, 1992, 26 (03) : 265 - 272
  • [42] Furosemide continuous infusion versus repeated injection in the management of acute decompensated heart failure in infants with left to right shunt: a randomized trial
    Marwa Zarzor
    Bothina Hasaneen
    Mohamed Magdy Abouelkheir
    Hanan El-Halaby
    [J]. Egyptian Pediatric Association Gazette, 71
  • [43] Relation between neurohormonal activation and enhanced ventilatory response to exercise in patients with chronic congestive heart failure
    Kinugawa, T
    Tomikura, Y
    Ogino, K
    Osaki, S
    Kato, M
    Igawa, O
    Hisatome, I
    Shigemasa, C
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (05): : 604 - +
  • [44] Torasemide versus furosemide in patients with congestive heart failure: A double-masked, randomized study
    Ferrara, N
    Leosco, D
    DelPrete, M
    Lombardi, L
    Landino, P
    Abete, P
    Longobardi, G
    Rengo, E
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1997, 58 (05): : 291 - 299
  • [45] Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials
    Ng, K. T.
    Yap, J. L. L.
    [J]. ANAESTHESIA, 2018, 73 (02) : 238 - 247
  • [46] EFFECT OF VARIOUS MODALITIES OF ORAL FUROSEMIDE IN PATIENTS WITH CONGESTIVE-HEART-FAILURE (CHF)
    DISHI, V
    COHEN, N
    GOLIK, A
    SOBACK, S
    WEISSGARTEN, J
    AVERBUKH, Z
    ZAIDENSTEIN, R
    MODAI, D
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 201 - 201
  • [47] Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure
    Paterna, S
    Di Pasquale, P
    Parrinello, G
    Amato, P
    Cardinale, A
    Follone, G
    Giubilato, A
    Licata, G
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2000, 2 (03) : 305 - 313
  • [48] Neurohormonal activation at rest and at peak exercise in patients with congestive heart failure (NYHA class 1-3)
    Boomsma, F
    Wijbenga, A
    Jonkman, F
    van den Meiracker, R
    in't Veld, AJM
    [J]. JOURNAL OF HYPERTENSION, 1998, 16 : S230 - S230
  • [49] Effect of vesnarinone on cardiac function in patients with severe congestive heart failure
    ScherrerCrosbie, M
    CoccaSpofford, D
    DiSalvo, TG
    Semigran, MJ
    Dec, GW
    Picard, MH
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 17142 - 17142
  • [50] Effect of vesnarinone on cardiac function in patients with severe congestive heart failure
    Scherrer-Crosbie, M
    Cocca-Spofford, D
    DiSalvo, TG
    Semigran, MJ
    Dec, GW
    Picard, MH
    [J]. AMERICAN HEART JOURNAL, 1998, 136 (05) : 769 - 777